Introduction: Atherosclerosis is the major source of morbidity and mortality in the developed countries like Libya. Oxidative stress represents a risk factor and plays a key role at several steps of atherosclerosis. Formation of atherosclerotic plaques is the main reason for coronary artery disease. Aim: This study is aimed to assess the impact of the imbalance between body oxidants and antioxidants (oxidative stress) and its involvement in developing and severity of atherosclerosis in atherosclerotic with and without diabetes Libyan patients. Methods: The study sample comprised of atherosclerosis with and without diabetes patients (n = 73), as well as healthy controls (n = 27). Blood samples were collected to determine the levels of malonaldehyde (MDA) as oxidative biomarker, serum selenium level, total antioxidant status (TAS) level and some antioxidant enzymes including glutathione peroxidase (GPx), Catalase (Cat) and superoxide dismutase (SOD). Additionally, oxidant/antioxidant status was compared between atherosclerotic patients with and without diabetes in comparison to controls. Results: The results indicated a significant increase in MDA level among atherosclerotic patients compared to healthy subjects (P < 0.05). While the level of TAS, Cat, SOD and GPx was significantly decreased among patients compared to the controls (P < 0.05). For the atherosclerotic diabetic patients, the study was found a rise in the level of MDA as well as a marked decrease in TAS and the activity of tested antioxidant enzymes (P < 0.05). A good correlation was obtained between elevated MDA and decreased TAS, Cat, SOD and GPx. Conclusion: Determination of antioxidative defense markers contributes to understanding the effect of oxidative stress on the development and the prevention of cardiovascular disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.